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Charcot-Leyden  crystals  (CLC) ~ are  characteristically  associated  with  diseases 
involving tissue or blood eosinophilia and are considered to be a hallmark of eosinophil 
involvement  in  the  tissue  reactions  of asthma,  myeloid  leukemia,  and  allergic  and 
parasitic  diseases  (1-3).  The protein  comprising the CLC has been shown to possess 
lysophospholipase  activity  (lysolecithin  acylhydrolase, EC  3.1.1.5),  and  purified  hu- 
man  eosinophil  lysophospholipase  crystallizes  to  form  the  hexagonal  bipyramidal 
crystals typical of CLC  (4).  The CLC protein  is a  slightly acidic molecule of 13,000 
mol wt  (5,  6),  with  one  free sulfhydryl group  (6)  that  is  required  for its  enzymatic 
activity (7). 
Although CLC are currently thought  to be distinctive  to eosinophils  (1,  2, 8),  the 
uniqueness  of CLC  to eosinophils  has  been  questioned.  Archer  and  Blackwood  (9) 
reported that CLC could be prepared  from human basophils, and they described the 
formation  of CLC  from  both  basophil  extracts  and  intact  basophils  suspended  in 
hypotonic sodium chloride.  Because the basophils they studied were obtained from a 
patient with tropical eosinophilia and their identity as basophils was not demonstrated 
histochemically,  their  findings  have  been  dismissed  in  the  literature  as  due  to 
contamination of basophil preparations with eosinophils, which in hypereosinophilic 
syndromes  may show  aberrant  staining  of the  granules  (1).  Bessis  and  Tabuis  (10) 
also reported that basophils form small, fusiform, nonstaining crystals similar to CLC 
after exposure to a  hypotonic sodium chloride solution. 
The present  study was conducted to test  the hypothesis that CLC and the protein 
comprising  the crystal  may be derived  from human  basophils.  Using a  radioimmu- 
noassay specific  for the  human  eosinophil  CLC  protein  (6)  and  a  double-antibody 
immunofluorescence  procedure, we showed that  human  basophils contain  a  protein 
immunochemically identical  to that  of the eosinophil  CLC protein.  In addition,  we 
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demonstrated the formation of crystals in basophils that are morphologically indistin- 
guishable from eosinophil CLC. 
Materials and Methods 
Preparation of Basophil,  Eosinophil,  Neutrophil,  and Mononuclear Rich  Cell Suspensions.  Highly 
enriched basophil suspensions for observation of spontaneous CLC formation and for immu- 
nofluorescence localization of CLC protein were prepared by flow microfiuorometry using a 
fluorescence-activated cell  sorter  (FACS IV,  B-D FACS Systems,  Becton, Dickinson & Co., 
Sunnyvale, CA)  (G. J. Weil and T. M. Chused, manuscript in preparation). Briefly, mononu- 
clear cells (11) from normal venous blood were labeled with a  1/50 dilution of the IgG fraction 
of fluoresceinated sheep anti-human IgE (N. L. Cappel Laboratories Inc., Cochranville, PA) in 
Hanks' balanced salt solution (HBSS)  (Gibco, Grand Island, NY) with 5 mM EDTA and 0.1% 
bovine serum albumin (HBSS-EDTA-BSA) (Sigma Chemical Co.,  St. Louis,  MO) at 0°C for 
30 min. After washing in HBSS-EDTA-BSA, the cells were sorted using the FACS IV. Sorted 
cells were stained for basophils with alcian blue and counted in a hemocytometer, as described 
by Gilbert and Ornstein (12). Differential cell counts were performed on both cytocentrifuge 
slides  fixed  with  absolute methanol and  stained with  Wright's stain or  fixed  with  Mota's 
fixative and stained with toluidine blue (13). 400  cells were counted at  a  magnification of 
x  1,000. 
Cell  suspensions used  for  the  preparation  of freeze-thaw  extracts  were  prepared  in  the 
following manner: eosinophils and neutrophils were separated with an FACS (FACS II, Becton, 
Dickinson & Co.),  using differential cell autofluoreseence as previously described (14). Highly 
enriched basophil suspensions were prepared by flow microfluorometry in a similar manner as 
described above. Briefly, mononuclear  cells were labeled with a 1/100 dilution of fluoresceinated 
goat anti-human IgE (N.  L.  Cappel Laboratories Inc.). After washing, the cells were sorted 
using the FACS II, counted, and samples were  frozen  at -70°C in HBSS-EDTA-BSA. Cells 
were  counted with a Coulter Counter (Coulter Electronics Inc., Hialeah, FL), and basophils 
were stained with alcian blue (12). Sorted basophils contained normal amounts of histamine 
and were >90% viable, as determined by trypan blue exclusion (G. J. Weil and T. M. Chused, 
manuscript in preparation). Differential cell counts of eosinophils, neutrophils, and mononu- 
clear ceils were performed on smears stained with l% fast green (Harleco, American Hospital 
Supply Corp., Gibbstown, NJ)  in methanol for  1 min, followed by 1% neutral red (Harleco) in 
distilled water for 5 min. 200 cells were counted at a magnification of × 400. 
hnmunofluorescence Localization of CLC Protein in Eosinophils and Basophils.  Cytocentrifuge slides 
of human peripheral blood buffy coat cells, Ficoll-Hypaque interface cells, or FACS-purified 
preparations of basophils were stained for CLC protein by an immunofluorescence procedure 
peviously described (t5).  Briefly,  slides  were fixed  for  10 min in absolute methanol, washed 
three  times with  Dulbecco's phosphate-buffered saline (PBS)  (5  rain per wash)  in staining 
dishes  on a  rocker platform, and incubated overnight in  10%  heat-inactivated normal goat 
serum  in  PBS  at  4°C.  Slides  were  washed  three  times with  PBS,  placed  in a  humidified 
chamber, overlaid with a  1/40 dilution of either control normal rabbit sera, preimmunization 
sera from rabbits immunized with CLC protein, or rabbit anti-CLC protein, and incubated 
overnight at  4°C.  Slides were washed three times with PBS,  stained for  30  min with a  I% 
solution of chromotrope 2R  (15670;  Harleco) at  room temperature, and washed again with 
PBS. In the second stage of the immunofluorescence  assay, the slides were overlaid with a  1/40 
dilution of IgG fraction of fluorescein-conjugated goat anti-rabbit IgG (13823;  N.  L. Cappel 
Laboratories Inc.) and incubated for 30 min at 37°C. Slides were washed three times with PBS, 
mounted in 50% 0.01 M  Tris and 50% glycerine solution, coverslipped, and sealed with nail 
polish. Slides were examined with a Zeiss standard microscope (Carl Zeiss, Inc., Oberkochen, 
West  Germany)  equipped  with  Zeiss  IV  FL  vertical  illumination for  epifluorescence and 
fluorescein filter system (487710;  Zeiss). Immunofluorescence  was photographed using Kodak 
Ektachrome 400 ASA slide film (Eastman Kodak Co.,  Rochester, NY)  and exposure times of 
60-120 s. The background fluorescence resulting from the treatment of Ficoll-Hypague  interface 
cells with fluoresceinated sheep anti-human IgE (Fc epsilon specific) before cell sorting in the 
FACS was minimal and did not interfere with the bright specific staining for CLC protein. 
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controls were used for immunofluorescence staining of CLC protein in eosinophils and basophils. 
First, preimmunization sera from individual rabbits were compared with the immunofluores- 
cence obtained with sera from the same rabbits after immunization with CLC protein. Second, 
rabbit anti-CLC sera were absorbed with human  serum albumin-Sepharose (HSA), human 
eosinophil granule major basic protein-Sepharose (MBP), CLC protein-Sepharose, or Sepharose 
alone before their use as the first stage reagent for immunofluorescence. Sepharose 4B and CL- 
6B  were  activated by cyanogen  bromide;  2  mg  of HSA or MBP  was  coupled  to  1 ml  of 
Sepharose 4B, and 4.4 mg of CLC protein was coupled to 10 ml Sepharose CL-6B. Uncoupled 
sites were blocked with 0.1  M  lysine monohydrochloride. Protein-Sepharose conjugates were 
washed with 0.05 M  glycine-HCl buffer, pH 3.0, and used to absorb sera (1 ml conjugate to 2 
ml of a  1:10 serum dilution). 
Preparation of Cell Extracts.  Basophil, eosinophil, neutrophil, and mononuclear cell-enriched 
suspensions in HBSS-EDTA-BSA were subjected to five successive freeze-thaw cycles using dry 
ice acetone and 37°C water bath, with vortexing between each cycle. Extracts were centrifuged 
at  12,000 g for 10 rain. The resulting clear supernatants were stored on ice, and CLC protein 
levels were measured immediately by radioimmunoassay. 
Measurement of CLC Protein Levels in Cell Extracts by Radioimmunoassay.  CLC protein concentra- 
tions in the cell extracts were measured by a double-antibody radioimmunoassay, as previously 
described (6).  Briefly, the radioimmunoassay was performed by adding 0.1  ml of a  5 ×  10 -3 
dilution of rabbit anti-CLC antibody, 0.5 ml assay buffer, and 0.1  ml of dilutions of the cell 
extracts or purified CLC protein to 10- ×  75-mm glass tubes. The contents were incubated at 
37°C for 30 min, after which 1 ng [13aI]CLC was added to each tube. Solutions were incubated 
overnight at 4°C, and the resulting immune complexes were precipitated by the addition of 0.1 
ml of a  1:20 dilution of normal rabbit serum and 0.1 ml of a burro anti-rabbit IgG antiserum. 
Tubes  were  incubated  at  4°C  for 2  h  and  centrifuged  for  20  min  at  2,500  g  at  4°C.  The 
supernatants were decanted, and  the sediments were counted in a  Nuclear Chicago gamma 
scintillation counter  (Searle  Radiographs  Inc.,  Des  Plaines,  IL).  Data  were  analyzed  by 
unweighted logit-log transformation using a Hewlett-Packard 9845B computer (Hewlett-Pack- 
ard Co., Palo Alto, CA) with radioimmunoassay program 09845-14254 and regression analysis 
methods program 09845-15014. 
Results 
CLC Formation  in  Basophil-enriched Cell Suspensions.  To  determine whether  human 
basophils  formed  crystals of similar  morphology  to  eosinophii  CLC,  we  prepared 
basophil-enriched cell suspensions using the FACS to enrich for surface IgE-positive 
leukocytes from peripheral blood mononuclear cells of normal individuals. These cell 
suspensions  contained  68%  (experiment  1)  and  54%  (experiment  2)  basophils,  as 
determined  by  alcian  blue  staining,  and  no  eosinophils  were  present  (Table  I). 
Basophil-enriched cell suspensions were incubated on ice for 24 or 48 h  in either PBS 
(experiment  1)  or  HBSS-EDTA-BSA  (experiment  2)  and  examined  for crystal  for- 
mation  (Fig.  1). At both 24 and 48 h, we observed the formation of crystals in many 
of the cells (Fig.  1 a). These crystals were morphologically similar to those previously 
described as forming from  both  eosinophils  (9,  16-18)  and  basophils (9,  10).  When 
basophil-enriched suspensions containing cells with crystals were pelleted onto micro- 
scope slides and stained with toluidine blue, we observed numerous intact basophils 
with characteristic metachromatic granules as well as many basophils that contained 
nonstaining, crystalloid inclusions typical of CLC  (Fig.  1 b, c). 
Detection  of  CLC  Protein  by  lmmunofluorescence.  To  determine  whether  basophits 
contained  immunoreactive CLC  protein, we stained cytocentrifuge slides of human 
buffy  coat  cells,  Ficoll-Hypaque interface  cells,  or  FACS-enriched  preparations  of 
basophils for CLC protein by immunofluorescence. When buffy coat cells were stained 
for CLC protein, a  small percentage of the cells stained with bright fluorescence (Fig. 1600  C|tARCOT-I,EYDEN  CRYSTAI,S  IN  HUMAN  BASOPHILS 
TABLE  I 
Analyses of Purified Basophil Preparations by Specific Histochemical Staimng and by 
hnmunofluorescence Staining for CLC Protein 
Differential cell counts* 
Percent positive 
Percent basophils  cells 
Immunofluo-  Alcian  Toluidine  Wright's 
Staining method}  blue:l:  blue§  stain§  rescence for 
CLC proteinll 
Experiment  1  68  ND¶  60  53 
Experiment 2  54  73  64  66 
* Differential cell counts of FACS IV-purified  basophils by alcian blue staining of 
cells in suspension or staining of cytocentrifuge slides with toluidine blue, Wright's 
stain,  or immunofluorescence  for CLC  protein.  Only intact  cells were counted. 
There were no eosinophils in these preparations,  and contaminating cells consisted 
of surface IgE-positive small [ymphocytes and rnonocytes. 
:~ Hemocytometer counts. 
§ Differential count on 400 cells. 
H  Differential count on 1,000 cells (experiment  I) or 300 cells (experiment 2). 
¶ Not done. 
2 a). These cells were identified as eosinophils by counterstaining the immunofluores- 
cence  slides  with  Wright's  stain  (Fig.  2 b),  Eosinophils  fluoresced  brightly  when 
stained with specific anti-CLC antibody but did not stain when normal rabbit sera or 
the preimmunization sera from CLC protein-immunized rabbits was used in the first 
stage of the  immunofluorescence  procedure.  Polymorphonuclear neutrophils,  eryth- 
rocytes, and mononuclear cells (lymphocytes and monocytes)  did not fluoresce when 
specific anti-CLC antibody was applied. However, an occasional cell could be found 
that  fluoresced with anti-CLC antibody but  could not be subsequently identified as 
an  eosinophil after the counterstain  with  Wright's stain.  These cells showed  diffuse 
cytoplasmic fluorescence (Fig. 2 c), and when counterstained with Wright's stain, they 
had a  nuclear morphology characteristic of a  polymorphonuclear leukocyte (Fig. 2 d). 
When cytocentrifuge slides of Ficoll-Hypaque interface cells were stained with anti- 
CLC antibody, a small percentage of cells fluoresced brightly with diffuse cytoplasmic 
staining  (Fig.  3 a,  c).  The  Ficoll-Hypaque interface  cell  population  was  primarily 
mononuclear  (lymphocytes and  monocytes)  and  was  slightly enriched  for basophils 
(~3%),  as  determined  by  alcian  blue  staining  of  cells  in  suspension.  This  cell 
population  did  not  contain  any  eosinophils  or  neutrophils,  as  determined  by  a 
differential cell count of Wright's stained cells. When these slides were counterstained 
with  Wright's  stain,  the  morphology  of  the  fluorescent  cells  was  not  distinctive, 
although  they possessed polymorphic nuclei (Fig. 3 b, d). 
To  determine  whether  enrichment  for  basophils  also  enriched  for  cells staining 
positively by immunofluorescence for CLC protein, immunofluorescence staining was 
performed on cytocentrifuge slides of FACS-purified basophil suspensions. As shown 
in  Table  I, >50%  of the surface  IgE-positive cell  population  in  both  experiments  1 
and 2 were basophils, as assessed by staining with alcian blue or by differential counts 
performed  on  cytocentrifuge  slides  stained  with  toluidine  blue  or  Wright's  stain. 
Differential  cell  counts  performed  on  duplicate slides stained  for  CLC  protein  by Fie.  I.  Spontaneous CLC formation in normal human blood  basophils.  10 #l  of cell suspension 
was placed on a  precleaned microscope slide, coverslipped, and sealed with nail polish. Cells were 
observed for crystal formation over a  period of 1 h  using a  Zeiss standard microscope with phase- 
contrast  optics.  (a)  Phase-contrast  photomicrograph  (X  1,000)  of a  normal  human basophil  sus- 
pended in  PBS for 24 h, showing a  CLC in the cytoplasm. (b)  Photomicrograph of basophil on a 
cytocentrifuge slide prepared from the above cell suspension in part a, fixed with Mota's fixative for 
1 min  and  stained  with  toluidine  blue.  Note  the distinctive, nonstaining CLC  in  the cytoplasm 
(arrow),  the granularity of the cytoplasm, and nuclear morphology typical of the blood basophil. 
(c)  Same  preparation  as  in  part  b,  showing  two  basophils,  one  of which  contains  a  typical, 
nonstaining CLC inclusion (arrow). 
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Fx6.  2.  Immunofluorescence staining of human peripheral blood leukocytes for CLC protein.  (a) 
Fluorescence photomicrograph (× 400) of a cytocentrifuge  slide of peripheral blood huffy coat cells 
stained  for  CLC  protein.  Note  the  two  cells  with  bright  membrane-like staining around  the 
periphery of the cells. (b) Identical field as in part a, counterstained with Wright's stain, showing 
that the two fluorescent cells in part a are eosinophils  (arrows). Note that mononuclear cells and 
neutrophils do not stain. (c) Another field from the same slide as in part a, showing four brightly 
fluorescent cells. Three of these ceils show the same pattern of fluorescent staining, while a fourth 
(arrow) shows a more diffuse cytoplasmic  staining. (d)  Identical field as in part c, counterstained 
with  Wright's stain, showing  that  three of the  fluorescent  cells are eosinophils  (closed arrows), 
whereas  the fourth cell (open arrow)  does not show the distinctive morphology  of the eosinophi[ 
lacking the bilobed nucleus and granules. 
immunofluorescence showed  that  >50%  of the cells in these  preparations  fluoresced 
brightly. Therefore, enrichment for surface IgE-positive cells (primarily basophils) by 
FACS also enriched  for cells staining positively for CLC  protein  by immunofluores- 
cence (Table I). 
Cytocentrifuge  slides  prepared  from  suspensions of FACS-purified  basophils  that 
had  formed  crystals  were  also  stained  for  CLC  protein  by  immunofluorescence. As 
shown in Fig. 4 a, cells containing crystals typical of CLC were observed under phase- 
contrast  illumination. These same cells showed  positive fluorescent staining for CLC 
protein, with bright  glowing around the perimeter of the crystal inclusion (Fig. 4  b). 
In  general,  intact  cells  without  crystals  stained  more  brightly  than  did  those  that 
contained  CLC,  possibly  because  of  depletion  of  CLC  protein  in  the  cell  and 
concentration of the  protein  in the  crystal  (Fig.  4 c).  When  cells containing crystals F
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FIG.  4.  Phase-contrast and immunofluorescence photomicrographs of purified basophils contain- 
ing CLC.  Slides  were  examined  first  by  phase-contrast illumination  to  identify cells containing 
crystals.  Cells  containing crystals were  photographed,  and  the  same  field  was  examined  under 
fluorescent  illumination  for  positive  fluorescent  staining of cells  and  crystals.  (a  and  d)  Phase- 
contrast photomicrographs (X  1,000)  of cells from purified basophil suspensions incubated for 24 h 
on  ice.  Note  the dark CLC  inclusions in  the cells  (arrows).  (b)  Immunofluorescence staining for 
CLC  protein  of the  same  field  as  in  part  a,  using  rabbit  anti-CLC  in  the  first  stage  of the 
immunofluorescence assay. Note the characteristic polymorphonuclear appearance of the basophil 
with  diffuse  cytoplasmic  staining  and  staining  around  the  periphery  of the  CLC  (arrow).  (c) 
Fluorescent staining of two basophils, one of which contains a  CLC.  Note the bright cytoplasmic 
staining of the cell at the bottom, as compared with the lower intensity cytoplasmic fluorescence of 
the cell  containing the  CLC.  Also note  the  bright  staining around  the  periphery  of the  crystal 
(arrow).  (e)  Immunofluorescence staining of the same field as in part d, using the preimmunization 
serum  in  the  first  stage of the  immunofluorescence assay.  Note  the  absence  of any  fluorescent 
staining of the cell or its CLC. S. J.  ACKERMAN,  G.  J.  WEIL,  AND  G.  J.  GLEICH  1605 
were stained  with  preimmunization  sera in the first stage, positive fluorescent staining 
was not observed  (Fig.  4  d, e). 
The  specificity of immunofluorescence  staining  for CLC  protein  in  basophils  and 
eosinophils  from  Ficoll-Hypaque  interface  cells or buffy  coat  cells, respectively,  was 
tested  by  absorbing  rabbit  antisera  with  various  solid-phase  protein-Sepharose  con- 
jugates  (Table  II)  and  using  these absorbed  sera in  the  first stage of the  immunoflu- 
orescence  assay.  Absorption  with  HSA-Sepharose,  MBP-Sepharose,  or unconjugated 
TABLE  II 
Specificity  of Immunofluorescence Staining for CLC Protein * 
Serum tested  Absorption§ 
Fluorescence* 
Basophil  Eosinophil 
Anti-CLC protein  None  +  + 
Anti-CLC protein  Unconjugated Sepharose  +  + 
Anti-CLC protein  HSA-Sepharose  +  + 
Anti-CLC protein  MBP-Sepharose  +  + 
Anti-CLC protein  CLC protein-Sepharose  -  - 
Preimmunization rabbit serum  None  -  - 
* The specificity of immunofluorescent staining for CLC protein in basophils and eosinophils was 
tested by staining cytocentrifuge slides of interface cells (primarily mononuclear cells and baso- 
phils) from Ficoll-Hypaque gradient centrifugation or of unseparated peripheral blood buffy coat 
cells, respectively. The identity of the fluorescent cells in buffy coat preparations as eosinophils 
was confirmed by counterstaining the slides with Wright's stain as in Fig. 2. 
:~ Symbols: +, very bright fluorescent staining of cells; -, absence of fluorescent staining of cells. 
§ Rabbit anti-CLC protein was absorbed with the various solid-phase immunosorbents before use 
as the first-stage reagent for immunofluorescence. 
TABLE  III 
Measurement  of CLC Protein Levels in Freeze-Thaw Extracts of Human Leukocytes by 
Radioimmunoassay  * 
Differential cell counts~:  Total 
Cell extract  number  ng  pg  pg 
Mono-  CLC/  CLC/  CLC/  tested§  of cells  Baso-  Eosino-  Neutro-  nu-  extract  cell  Baso 
(×  10  -'~)  phil  phil  clear  phil 
Pg 
CLC/ 
Eos 
Experiment  1 
Basophil  1.50  99  0  1  0  448  3.0  2.98 
Eosinophil  6.40  0  ~  0  10  492l  7.7  -- 
Neutrophil  41.60  0  1.5  0  98.5  860  0.2  -- 
Experiment 2 
Basophil  0.35  97  0  3  0  1085  31.0  31.9 
Unseparated 
Mononuclear  36.50  3  <1  97  0  1285  0.4  -- 
8.5 
13.8 
* CLC  protein  levels  in  supernatams  of freeze-thaw extracts  of basophil,  eosinophil,  neutrophil,  and 
mononuclear cell-enriched preparations were determined by radioimmunoassay. Cells were extracted by 
five successive freeze-thaw cycles using dry ice acetone and 37°C water bath with vortexing between each 
cycle, followed by centrifugation for 10 rain at  12,000 g. 
:~ Differential cell counts were performed as described in Materials and Methods. 
§ Cells were extracted in total volumes of 0.28, 0.19, and 0.4 ml for basophil, eosinophil, and neutrophil 
preparations in experiment I, and volumes of 0.5 ml for the basophil and unseparated mononuclear cell 
preparations in experiment 2. 1606  CHARCOT-LEYDEN  CRYSTALS  IN  HUMAN  BASOPHILS 
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20  0  2  4  6  8  10  -2.0  -~.0  0.0  1.0  ' 
80  1.6  . 
60  0.8  "J 
40  0.0 
20  I  I  |  I  0.6 
0  2  4  6  6  ~0  - t,0  "0.5  0,0  0.5  1.0 
/~1 cell extract or  Log~0P.l  cell extract or 
CLC  concentration  (ng)  Log  CLC  concentration 
F=c.  5.  Inhibition of the binding of [~3~I]CLC to specific rabbit antibody by CLC protein standard 
and  freeze-thaw extracts of human  basophils, eosinophils, neutrophils, and  mixed  mononuclear 
leukocytes. Inhibition curves produced in experiment 1 (A) and experiment 2 (C)  when increasing 
quantities of CLC protein standard (0)  or increasing amounts of freeze-thaw extracts of purified 
human  basophils (C)), eosinophils ([-I),  neutrophils  (B), or unseparated  mononuclear leukocytes 
(&) were measured by radioimmunoassay. (B and D) Regression lines for lo~it-log transformed data 
from  panels A  and  C,  respectively. The coefficients of determination  (r)  for the CLC  protein 
standard inhibition regression lines were 0.992 and 0.993 and for cell extracts averaged 0.98 ±  0.007 
and 0.99  ±  0.004  for experiments  1 and  2,  respectively. A  statistical  analysis of these logit-log 
regression lines revealed that  the null hypothesis of common slope could not be rejected (F3,]z = 
1.86; NS and F2,s =  3.94;  NS for experiments 1 and 2, respectively). 
Sepharose did not abrogate fluorescence staining of the cells.  In contrast, absorption 
with CLC protein-Sepharose completely eliminated fluorescence staining. No staining 
occurred with the preimmunization sera. 
Measurement of CLC  Protein in  Freeze-Thaw Extracts of FACS-pur~ed  Basophils by 
Radioimmunoassay.  To  test  whether  basophils  and  eosinophils  contained  similar 
amounts of CLC protein, we measured CLC protein concentrations in the superna- 
tants of freeze-thaw extracts of cell suspensions  enriched for basophils,  eosinophils, 
neutrophils, or mononuclear cells by radioimmunoassay (Table III). CLC protein was 
detected  in  all  freeze-thaw cell  extracts  that  contained  eosinophils  as  well  as  in 
basophil extracts derived from highly purified basophils (99 and 97% pure, with no 
contaminating eosinophils, experiments 1 and 2, respectively). When the CLC protein 
concentrations on  a  per cell basis  were calculated  for the  basophil  and  eosinophil 
extracts, they contained significantly more CLC protein than did the neutrophil or 
unseparated  mononuclear  cell  extracts  (Table  III).  We  also  calculated  the  CLC 
protein concentrations per eosinophil and basophil in these experiments, and roughly 
comparable picogram quantities of CLC protein per cell were extracted by the freeze- 
thaw procedure (Table III). 
The radioimmunoassay measures CLC protein concentration by inhibition of the 
binding  of radiolabeled  [131I]CLC to  specific  antibody.  Fig.  5 a  and  c  shows  the 
radioimmunoassay inhibition curves obtained when  increasing quantities of freeze- 
thaw extracts of the purified cell suspensions were reacted with specific antibody to 
CLC  protein  and  1 ng  [131I]CLC. The shapes  of these  inhibition curves were very S.  J.  ACKERMAN,  G.  J.  WEIL,  AND  G.  J.  GLEICH  1607 
similar for both experiments. Fig. 5 b and d shows the logit-log transformed data for 
these assays. A  statistical comparison of these regression  lines failed to  reveal  any 
significant differences in their slopes.  The similarity of the inhibition curves of the 
basophil  extracts  to  those of the CLC  protein  standard and  to  other cell extracts 
containing eosinophils indicates that basophils contain a protein that is immunochem- 
ically indistinguishable from that of the eosinophil CLC protein. 
Discussion 
The CLC is currently believed to be distinct to the eosinophil and a  hallmark of 
active eosinophilic inflammation or proliferation in a variety of conditions character- 
ized by tissue or peripheral blood eosinophilia, including myeloid leukemias, eosino- 
philic granuloma of bone, asthma and other allergic diseases, and parasitic diseases 
(1,  2).  The  finding by Weller et  al.  (4)  that the protein comprising the eosinophil 
CLC possesses lysophospholipase activity (lysolecithin acylhydrolase, EC 3.1.1.5)  and 
that chromatographically purified human eosinophil lysophospholipase crystallizes to 
form the hexagonal bipyramidal crystals typical of CLC has stimulated interest in the 
possible importance of CLC protein to eosinophii function. The uniqueness of CLC 
to eosinophils has not been clearly substantiated in the scientific literature, and the 
possibility existed that  CLC might also be  derived from human basophils,  as first 
proposed by Archer and Blackwood in  1965 (9). 
In  the  present  study, we  tested  the  hypothesis that  CLC  form  from  basophils. 
Basophils possess considerable quantities of IgE on their surface, and we enriched for 
surface IgE-positive cells using the FACS to obtain preparations of cells containing 
up to 99% basophils, without any contaminating eosinophils (Tables I and III). We 
examined these  basophil-enriched cell suspensions  for the ability to spontaneously 
form  crystals.  In  two  separate  experiments,  cells  in  suspensions  containing >50% 
basophils and no eosinophils spontaneously formed crystals with the characteristic 
morphology of CLC (Fig.  1). When cells from these suspensions were pelleted onto 
microscope slides and stained  by a  histochemical procedure  specific for basophils, 
crystal-containing cells stained  as  basophils,  and  the  nonstaining crystals had  the 
typical  appearance  of CLC  (Fig.  1).  By  using  an  immunofluorescence procedure 
specific for eosinophil CLC protein, we demonstrated the presence of immunoreactive 
CLC protein in Ficoll-Hypaque interface cell preparations containing mononuclear 
cells, basophils, and no eosinophils and in basophil-enriched cell suspensions prepared 
by FACS purification of IgE-bearing cells.  In these experiments, basophil-enriched 
cell suspensions contained >50% basophils, as determined by three different staining 
procedures, and >50% of these cells also fluoresced brightly when stained for CLC 
protein  (Table  I).  In  addition,  examination  of basophil-enriched  cell  suspensions 
containing CLC by immunofluorescence showed the presence of CLC in cells staining 
with positive fluorescence (Fig.  4).  Finally, we demonstrated the presence  of CLC 
protein in basophils by preparing freeze-thaw extracts of highly purified suspensions 
of basophils,  eosinophils,  neutrophils,  and  mononuclear  cells  and  comparing  the 
ability of these extracts to inhibit the binding of radiolabeled CLC protein to specific 
antibody in a radioimmunoassay. The results of these experiments (Table III, Fig. 5) 
indicate that basophils contain a protein that is immunochemically indistinguishable 
from that of eosinophil CLC protein and that  the quantity of CLC protein in the 
basophil  approximates  that  of  the  eosinophil.  In  contrast,  on  a  per  cell  basis, 1608  CttARCOT-I,EYDEN  CRYSTALS IN ttUMAN  BASOPttILS 
neutrophils  and  mononuclear cells contained  very small quantities  of CLC protein, 
which  presumably  resulted  from  the  presence  of small  numbers  of contaminating 
basophils or eosinophils in these cell populations. 
Based  upon  these  findings,  the  CLC  can  no  longer be considered  unique  to  the 
eosinophil. Basophils obtained from normal individuals can spontaneously form CLC 
under  appropriate  conditions,  and  basophils  can  be shown  to  contain  measurable 
quantities of CLC protein, as determined by radioimmunoassay and immunofluores- 
cence. Therefore, we must now regard the presence of CLC in tissues, sputum, or stool 
as indicative of the presence of either eosinophils or basophils. 
Summary 
Charcot-Leyden crystals (CLC) are currently believed to be unique to the eosinophil 
and a hallmark of active eosinophilic inflammation or proliferation. The distinctive- 
ness of the CLC to the eosinophil was questioned  in  1965  by Archer and Blackwood 
(9),  but  their  demonstration  of CLC  formation in  basophils  was  ignored  and  later 
dismissed (I) as being the result ofeosinophil contamination of basophil-enriched cell 
suspensions. 
We reexamined this question and showed that basophils obtained from the periph- 
eral blood of normal individuals form CLC and that basophils contain a protein that 
is immunochemically indistinguishable  from eosinophil CLC protein. These conclu- 
sions are based upon the findings that  (a) crystal formation in basophils was demon- 
strated by specific histochemical staining of crystal-containing cells in highly enriched 
basophil suspensions prepared by fluorescence-activated cell sorter (FACS)  purifica- 
tion  of surface  IgE-positive cells,  (b)  that  enrichment  for surface  IgE-positive cells 
(primarily  basophils)  by  the  FACS  also  enriched  for  cells  staining  positively  by 
immunofluorescence  for  eosinophil  CLC  protein,  and  (c)  that  CLC  protein  was 
measured  by  radioimmunoassay  in  cell  extracts  prepared  from  purified  basophil 
suspensions  containing  97-99%  basophils  and  absolutely  no contaminating  eosino- 
phils. These basophil extracts contained  a  protein immunochemically indistinguish- 
able from eosinophil CLC protein. 
Based  upon  these  findings,  the  CLC  or the  protein  comprising the  crystal  (lyso- 
phospholipase) can no longer be considered as distinctive to the eosinophil. We must 
now consider the possibility that the presence of CLC in tissues, sputum, or stool may 
also represent basophil involvement in disease processes. 
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